Tokenization under the EU Regulations with Smartlands Will Define the Future of Investment Banking
The volatile nature of the cryptocurrency market is the largest threat that keeps a majority of investors away from the industry, and many businesses from wide adoption of blockchain. The Smartlands Platform solves this challenge by creating the necessary legal framework to enforce assets tokenization in full compliance with the law.
Smartlands is going to employ a crowdfunding platform license to create a solid foundation for the future of assets tokenization within the platform. In order to be fully compliant with the law, the company plans further expansion by launching a new office in Vilnius.
Asset-backed tokens issued on Smartlands, under crowdfunding platform license, will be sold as securities. The tokens will combine the advantages of blockchain technology and classical investment instruments. They will be in compliance with the legislation of the European Union, provide greater protection for investors, and will be a secure tool to attract investments for companies, whilst providing flexibility to a crowdfunding framework.
How Smartlands Can Ensure Stability for the Cryptocurrency-Based Economy
We have carefully chosen Lithuania, because it is one of the few countries with very clear and concise legislation governing crowdfunding, cryptocurrencies, and related institutions. The development of the cryptocurrency market in the country is welcomed by the authorities, while Lithuania is part of the EU so tokens issued in compliance with its legislation gains the full access to the EU, EEA, and other markets.
Next Steps in the Smartlands Platform Expansion
Following this expansion, we have our eyes set on the United Kingdom. The UK is a primary location in our growth roadmap, and we plan to acquire a similar license there, as we are doing in Lithuania.
The UK is a hotbed of FinTech developments, large potential investors, and international investment opportunities. Many of the UK-based real estate assets are potential targets for tokenization, so further expanding into the UK opens up to more opportunities for efficient investments, capital growth and asset synergy to Smartlands.
Smartlands is a worldwide Platform for tokenization of real economy. Smartlands is built on the Stellar network and employs advanced blockchain technology with fast, secure transactions and extended capabilities.
Smartlands on CoinMarketCap: coinmarketcap.com/currencies/smartlands
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
Victor Yermak (Business Development Director)
Smartlands Platform Foundation Company
+359 895046445 (telegram)
About Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Bank of Queensland Goes Live on Temenos Banking Cloud18.8.2022 08:30:00 CEST | Press release
Temenos (SIX: TEMN) today announced that Bank of Queensland (BOQ) has gone live with retail banking services on Temenos Banking Cloud for customers served under the BOQ and Virgin Money brands. Work has commenced on the migration of BOQ’s ME brand to Temenos Banking Cloud. Using Temenos cloud-based platform enables BOQ to offer superior customer propositions with personalized offerings at a fraction of the cost of its legacy systems, building a competitive advantage and a low cost-income ratio. Since go live, BOQ has completed over four million transactions on the new platform. The modernization project with Temenos simplifies BOQ’s technology landscape by consolidating 40 systems to a single platform for retail and business banking. As part of the project, BOQ Group will migrate all of its banking operations across three banking brands – leading regional bank BOQ, and challenger banks Virgin Money and ME Bank. BOQ Group is progressively rolling out the Temenos Banking Cloud across the
Altium, IPC Education Foundation, and Arduino Announce Student Electronics Design Competition18.8.2022 07:00:00 CEST | Press release
Altium LLC, the leading printed circuit board (PCB) design software company, is partnering with the IPC Education Foundation (IPCEF) and Arduino to launch the second annual student electronics design challenge. This competition aims to engage, educate, and enhance PCB design capabilities while developing STEM solutions to environmental challenges. The electronics design challenge is an excellent opportunity for students to showcase their talents and gain real-world experience. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220817005660/en/ Altium LLC, the IPC Education Foundation, and Arduino are partnering to launch the second annual student electronics design challenge to engage, educate, and enhance students’ proficiencies in PCB design capabilities with a focus on solving some of the world’s most pressing environmental challenges. (Photo: Altium LLC) The Innovation for Environmental Change 2022 International Student Desi
Tavneos ® (avacopan) recommended by England’s NICE for the treatment of AAV (GPA/MPA)18.8.2022 07:00:00 CEST | Press release
Vifor Fresenius Medical Care Renal Pharma (VFMCRP) is pleased to announce that England’s National Institute for Health and Care Excellence (NICE) has recommended Tavneos® in combination with a rituximab or cyclophosphamide regimen for the treatment of adult patients with severe, active granulomatosis polyangiitis (GPA) or microscopic polyangiitis (MPA), two main forms of AAV. The decision follows authorization from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) in May 2022. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220817005538/en/ “ANCA-associated vasculitis is a rare, systemic disease which can be rapidly fatal if not appropriately & promptly treated. The variable nature of the disease and its course along with challenging side-effects of current treatment options can severely affect subsequent quality of life for patients,” said John Mills, Vice-Chair of Vasculitis UK. “We very much welcome NICE’
Pre-registration Opens for Hotly Anticipated Racing Game KartRider: Drift18.8.2022 06:01:00 CEST | Press release
Starting today, Nexon’s upcoming party game, KartRider: Drift, is opening pre-registration to racers in preparation for the game’s launch on PC (Steam and Nexon Launcher), Xbox One, PlayStation 4, and mobile (iOS and Android). Kart racer fans who sign up beforehand can receive a special character Model Student Diz when the game officially launches. Additionally, an upcoming cross-platform play test will be announced soon. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220817005798/en/ Nexon America KartRider: Drift (Graphic: Nexon) KartRider: Drift boasts multiple game modes and features, delivering exciting racing gameplay regardless of what platform you choose to play. 3 Thrilling Game Modes – Racers can test their grit in “Speed Mode,” a fast-paced mode that will test a racer's reaction skills and strategy using boosts. “Item Mode” offers a wide variety of usable items to attack opposing teams or defend their allies. Fina
Exscientia Business Update for Second Quarter and First Half 202217.8.2022 22:01:00 CEST | Press release
Exscientia plc (Nasdaq: EXAI) This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220817005681/en/ Recent developments in the Company’s pipeline, collaborations, and operations, as well as financial results for the second quarter and first half 2022, are summarised below. In addition, Exscientia will host a conference call Thursday, August 18 at 1:30 p.m. BST / 8:30 a.m. ET to provide an overview of the company’s pipeline and corporate strategy. “In the first half of 2022, we delivered on major new and existing collaborations, advanced our pipeline programmes, and marked the 10-year anniversary of Exscientia’s founding. Over the past decade, we’ve pioneered an AI-driven approach to modernising drug discovery and development, and it was fitting that this quarter we also announced topline data from our EXS-21546 programme, one of the first AI-designed molecules to enter clinical trials,” said Andrew Hopkins, D.Phil., Exscientia's f